HPIC Team welcome new customers Fagus Antibody Services
We are excited to have Fagus Antibody Services join the centre. Already they are recruiting for more scientists to join their team. They offer a complete solution for all your antibody requirements. Antibodies are specialised proteins that can specifically recognise and bind, with high affinity, to a huge range of […]
Heyford Park Business Community – Customer Spotlight Series
Xerion’s technology increases the ability of radiotherapy to kill cancer cells without harming healthy tissue Pioneering technology Xerion’s technology improves the effectiveness of conventional radiotherapy while minimising side-effects. The company’s Oxilia nanoparticles have a physical mode of action and offer the ability to improve treatment of a wide range of […]
Pioneering tissue regeneration technology start-up, Oxartis, wins bio-kickstart competition at HPIC
We are delighted to welcome Oxartis to Heyford Park Innovation Centre as our successful bio-kickstart competition winner. Oxartis is a bio-medical start-up that is developing tissue regeneration technology to transform the lives of patients who have suffered significant tissue loss, including burn injury or trauma as well as patients who […]
Former HPIC customers DJS Antibodies has just been acquired by AbbVie for $255 million
Congratulations to DJS Antibodies, a biotechnology company dedicated to creating the next generation of antibody therapeutics, who started life at HPIC using shared lab bench space and have just been acquired by AbbVie for $255 million. HPIC are currently asking bio tech start-ups to apply for the opportunity to secure […]
WIN! Enter today to get your biotech idea off to a flying start
Are you an innovative start-up (less than 12 months old) with a business idea that is beneficial to the environment and/or human health?
Air Purity and Neutronix created the world’s first air disinfection system to combat airborne infections, including SARS-CoV-2
A next generation solution for infection prevention has been pioneered by Air Purity UK, alongside Neutronix who are based at HPIC. Whilst initial findings have been described as ‘groundbreaking,’ the full report on the world’s first clinical study of its kind is anticipated to be published until May 2023
Two of HPIC residents are finalists in the Cherwell Business Awards
Two of the three finalists in the category for Oxford Technology Park – Innovation Award are Nikalyte and Oxford Oxford StemTech both residents of HPIC.
Heyford Park goes viral
To celebrate International Women’s Day, we wanted to put the spotlight on our Innovation Director Wendy Tindsley. With a wealth of experience in business development and a passion for technology, Wendy supports, inspires and empowers businesses in our centres to reach their full potential.
Nikalyte Ltd announces new partnership with Wasatch Photonics to advance application of SERS
Nikalyte Ltd. and Wasatch Photonics are pleased to announce a partnership to facilitate evaluation and testing of a novel SERS substrate for trace detection of materials, with applications in narcotics, food safety, pharmaceuticals, environmental, and biological analysis. Together, Nikalyte and Wasatch Photonics are evaluating the performance of these new SERS, […]
ConserV Bioscience developing a suite of life-changing vaccines
We are immensely proud of the fact that Heyford Park based ConserV Bioscience has been very much in the news recently for developing a suite of life-changing vaccines ConserV specialises in the design of vaccines against conserved protein regions of viruses. These regions do not evolve over time and remain […]
